Man who died after head surgery tested positive for Covid
road accident
on May 11, according to officials.
Health officials said the deceased, Govindhanathan, was admitted to a private hospital after an accident on May 11 and underwent FTP decompression craniotomy. He took a swab test at the private hospital on May 20, and the results returned positive on May 23. He was discharged from the hospital and was isolated at his home.
A health official told TOI, "He was admitted to MGMGH on June 5 with a poor Glasgow Coma Scale score.
Health staff came to know about the Covid history later and isolated him at the GH. But no retest was conducted due to a lack of testing availability at the time. Meanwhile, he died around 8.45am on Sunday."
The official denied that the cause of death was related to Covid-19. "The cause of death can be concluded only after an autopsy report comes," the official added.
Meanwhile, health officials reported that there are two active Covid-19 cases in the district. Both patients, a 25-year-old female and a 51-year-old male, are in home isolation.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
6 hours ago
- Time of India
Special drive to monitor stunting among kids at Noida anganwadi centres
N oida/Ghaziabad: A focused campaign has been launched to curb stunting and other forms of child malnutrition in GB Nagar and Ghaziabad districts, under the Sambhav Abhiyan 5.0. A total of 100 anganwadi centres in each district have been identified for close monitoring, based on the concentration of children under five showing signs of stunted growth. The campaign, which began on July 15 and will continue until July 31, focuses on growth measurement and real-time data verification. The aim is to identify children suffering from chronic malnutrition, update their health status on the nutrition tracker, and implement timely interventions, officials said. Previously, TOI had reported that, in GB Nagar, 789 children under the age of six were identified as severely acutely malnourished (SAM), and another 3,394 children were classified as moderately acutely malnourished (MAM). You Can Also Check: Noida AQI | Weather in Noida | Bank Holidays in Noida | Public Holidays in Noida GB Nagar district program officer Poonam Tiwari told TOI, "100 high-burden Anganwadi centres have been selected based on the Nutrition Tracker Report, which lists the specifications of the SAM and MAM children. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Đây có thể là thời điểm tốt nhất để giao dịch vàng trong 5 năm qua IC Markets Tìm hiểu thêm Undo These centres will undergo special inspections to track height, weight, and nutrition levels among children under six years of age." In Ghaziabad, a total of 415 children have been identified under the SAM category, while 3,500 children have been identified as MAM. "The nodal officer at each centre will take measurements in person based on name-wise lists. If discrepancies are found with the previously recorded Nutrition Tracker data, they will be corrected and noted in the report," said Shashi, district program officer in Ghaziabad.
Time of India
6 hours ago
- Time of India
TOI Impact: RUHS releases merit list for 1,700 med officer posts
Jaipur: The Rajasthan University of Health Sciences (RUHS) Tuesday released the merit list for appointment of 1,700 medical officers, days after TOI highlighted the inordinate delay in the declaration of results nearly three months after the exam. The recruitment process had been stalled since April 27, when the written exam was conducted. The release of the merit list now clears the way for filling long-pending vacancies for medical officers across the state. Medical officers play a crucial role in strengthening primary healthcare delivery. Many Primary Health Centres (PHCs) and Community Health Centres (CHCs) in Rajasthan currently function without doctors, affecting rural healthcare. "With the merit list out, the process of allotting postings to selected doctors will begin soon," said a senior health department official. Candidates will have to submit their posting preferences online. Based on their rank in the merit list, postings will be allocated accordingly, the official added. RUHS had been tasked with conducting the recruitment exam and managing the selection process, including release of the category-wise merit list. Document verification of about 3,400 candidates who cleared the exam was completed to ensure they met eligibility norms. Officials said, verification included checking for valid registration with the Rajasthan Medical Council, a mandatory requirement to practice in the state, along with scrutiny of disability and other reservation-related certificates. Based on these verified documents, RUHS will now finalise and release the detailed category-wise merit list, paving the way for formal appointments.
Time of India
7 hours ago
- Time of India
All about the 'Nimbus' and 'Stratus', the new COVID variants monitored closely by WHO
COVID-19 might not dominate the headlines anymore, but that doesn't mean it has stopped evolving. In fact, behind the scenes, scientists are closely tracking several offshoots of the Omicron variant. Tired of too many ads? go ad free now Two of those, unofficially nicknamed Nimbus and Stratus, are now on the radar for their quick global spread and potential to evade immunity. Here's a closer look at what we know so far. Nimbus (NB.1.8.1) First spotted in early 2025, NB.1.8.1, or 'Nimbus', has made its presence felt quickly. It is currently listed as a 'variant under monitoring' (VUM) by the World Health Organization (WHO), - meaning they may require prioritised attention and tracking by health authorities due to their increased prevalence and potential public health implications. By late April, it had jumped from 2.5% to over 11% of all sequenced COVID-19 cases, especially across parts of Asia and the Western Pacific. Further, as per TODAY, 43% of cases in the U.S. are driven by this variant. Nimbus is part of the Omicron family, and it's a recombinant virus — a mash-up of different viral lineages that combined genetic material. It descends from a complex mix involving XDV, which itself was formed by blending JN.1 and another hybrid known as XDE. Symptoms of Nimbus According to the Global Alliance for Vaccines and Immunizations (Gavi), the symptoms of the NB.1.8.1 variant include: runny nose, headache, fatigue, sneezing, and sore throat. Additionally, people also might feel a razor blade sensation in the throat, which is the defining symptom for this variant, and gastrointestinal symptoms, including: nausea, vomiting, diarrhea, heartburn, bloating, constipation, and stomach pain. Tired of too many ads? go ad free now As of July 9, test positivity is at 3.1%, 0.1% higher than the previous week, according to the . The World Health Organization (WHO), in its May 23 evaluation, stated there's no current evidence that Nimbus is more dangerous than the other Omicron subvariants circulating today. Further, it also states that the currently approved COVID-19 vaccines are still expected to be effective against this variant. Stratus (XFG) First detected in Canada, Stratus (XFG) it's already made significant jumps into Europe and India. By late May, it was behind a quarter of new cases in parts of Europe, overtaking even Nimbus. Stratus, too, has been classified by the WHO as 'Variant under Monitoring'. Stratus is also a recombinant. It formed when two earlier variants, LF.7 and LP.8.1.2, crossed paths and exchanged genetic code. Like most of its Omicron cousins, it spreads quickly, prefers the upper respiratory tract, and seems less likely to lead to severe illness. According to the current available data, symptoms of XFG are similar to those of other Omicron sub-variants which are typically mild upper respiratory symptoms. Symptoms of the XFG People infected with the XFG subvariant have reported a range of symptoms including: chills, shortness of breath, sore throat, fatigue, headache, nausea, vomiting, muscle and body aches, diarrhea, and in some cases, a loss of taste or smell. What sets XFG slightly apart, according to early reports, is one more noticeable symptom: hoarseness. Several individuals have described a rough or raspy voice, which may serve as a subtle clue when trying to distinguish this variant from other circulating strains.
